Effects of α-thalassemia on pharmacokinetics of the antimalarial agent artesunate

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2332-2335

  Ittarat, Wanida ^a   Looareesuwan, Sornchai ^b   Pootrakul, Pensri ^a   Sumpunsirikul, Petchmanee ^a   Vattanavibool, Phantip ^a   Meshnick, Steven R ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; DIHYDROARTEMISININ;

ALPHA THALASSEMIA; ANTIMALARIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; BLOOD SMEAR; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ERYTHROCYTE LEVEL; ERYTHROCYTE COUNT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALARIA; NEUROTOXICITY; PRIORITY JOURNAL; STEADY STATE; THROMBOCYTE COUNT;

EID: 0031679937     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2332     Document Type: Article

References (34)

1. Asawamahasakda, W., A. Benakis, and S. R. Meshnick. 1994. The interaction of artemisinin with red cell membranes. J. Lab. Clin. Med. 123:757-762.
2. Benakis, A., M. Paris, L. Loutan, C. T. Plessas, and S. T. Plessas. 1997. Pharmacokinetics of artemisinin and artesunate after oral-administration in healthy-volunteers. Am. J. Trop. Med. Hyg. 56:17-23.
3. Benet, L. Z., and N. Massoud. 1984. Pharmacokinetics, p. 1-28. In L. Z. Benet et al. (ed.), Pharmacokinetic basis for drug treatment. Raven Press, New York, N.Y.
4. Bethell, D. B., P. Tejaisavadharm, T. P. Cao, T. T. T. Pham, T. T. M. Ta, T. N. T. Tran, T. T. H. Nguyen, P. T. Phuong, D. Kyle, N. P. J. Day, and N. J. White. 1997. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:195-198.
5. Brewer, T. G., S. J. Grate, J. O. Peggins, P. J. Weina, J. M. Petras, B. S. Levine, B. M. H. Heiffer, and B. G. Schuster. 1994. Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51:251-259.
6. Cumming, J. N., P. Ploypradith, and G. H. Posner. 1997. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv. Pharmacol. 37:253-299.
7. Desjardins, R. E., C. J. Canfield, J. D. Hayne, and J. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
8. Duc, D. D., P. J. De Vries, N. X. Khanh, L. N. Binh, P. A. Kager, and C. J. Von Boxtel. 1994. The pharmacokinetics of a single dose of artemisinin in healthy Vietnameses subjects. Am. J. Trop. Med. Hyg. 51:785-790.
9. Edwards, G. 1994. Measurement of artemisinin and its derivatives in biological fluids. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):37-39.
10. Hien, T. T., and N. J. White. 1993. Qinghaosu. Lancet 341:603-608.
11. Kamchonwongpaisan, S., G. Chandra-ngam, M. A. Avery, and Y. Yuthavong. 1994. Resistance to artemisinin of malaria parasites (Plasmodium flaciparum) infecting α-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes. J. Clin. Invest. 93:467-473.
12. Kamchonwongpaisan, S., P. McKeever, P. Hossler, M. Y. Leung, H. Ziffer, and S. R. Meshnick. 1997. Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg. 56:7-12.
13. Krogstad, D. J. 1996. Malaria as a reemerging disease. Epidemiol. Rev. 18:77-89.
14. Li, G. Q., X. B. Guo, L. C. Fu, L. H. X. Jian, and X. H. Wang. 1994. Clinical trials of artemisinin in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):5-6.
15. Li, X., and K. Rieckmann. 1992. A bioassay for derivatives of qinghaosu (artemisinin). Trop. Med. Parasitol. 43:195-196.
16. Livingstone, F. B. 1985. Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations. Oxford University Press, New York, N.Y.
17. Looareesuwan, S. 1994. Overview of clinical studies on artemisinin derivatives in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):9-11.
18. Melendez, V., J. O. Peggins, T. G. Brewer, and A. D. Theoharides. 1991. Determination of antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high performance liquid chromatography with reductive electro-chemical detection. J. Pharm. Sci. 80:132-138.
19. Meshnick, S. M., T. E. Taylor, and S. Kamchonwongpaisan. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:301-315.
20. Miller, L. G., and C. B. Panosian. 1997. Ataxia and slurred speech after artesunate treatment for falciparum malaria. N. Engl. J. Med. 336:1328.
21. Navaratnam, K., S. M. Mansor, L. K. Chin, M. N. Mordi, N. Asokan, and N. K. Bair. 1995. Determination of artemether and dihydroartemisinin in blood plasma by high performance liquid chromatography for application in clinical pharmacological studies. J. Chromatogr. B 669:289-294.
22. Na-Bangchang, K., J. Krabwang, C. G. Thomas, A. Thanavibul, K. Sukontason, S. A. Ward, and G. Edwards. 1994. Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 37:249-253.
23. Senok, A. C., K. Li, E. A. S. Nelson, L. M. Yu, L. P. Tian, and S. J. Oppenhenmer. 1997. Invasion and growth of Plasmodium falciparum is inhibited in fractionated thalassemic erythrocytes. Trans. R. Soc. Trop. Med. Hyg. 91:138-143.
24. Song, Z. Y., and K. C. Zhao. 1989. Studies of qinghaosu and its active derivatives in biological materials and their pharmacokinetics. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll. 4:229-234.
25. Teja-Isavadharm, P., F. Nosten, D. E. Kyle, C. Luxemburger, F. Ter Kuile, J. O. Peggins, T. G. Brewer, and N. J. White. 1996. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatograpy and bioassay. Br. J. Clin. Pharmacol. 42:599-604.
26. Titulaer, H. A. C., J. Zuidema, P. A. Kager, J. C. F. M. Wetsteyn, C. H. B. Lugt, and F. W. H. M. Merkus. 1990. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J. Pharm. Pharmacol. 42:810-813.
27. Wanwimolruk, S., G. Edwards, S. A. Ward, and A. M. Breckenridge. 1992. The binding of the antimalarial arteether to plasma proteins in vitro. J. Pharm. Pharmacol. 44:940-942.
28. Wernsdorfer, W. H. 1994. Epidemiology of drug resistance in malaria. Acta Trop. 56:143-156.
29. Williams, T. N., K. Maitland, S. Bennett, M. Ganczakowski, T. E. A. Peto, C. I. Newbold, D. K. Bowden, D. J. Weatherall, and J. B. Clegg. 1996. High incidence of malaria in α-thalassemic children. Nature 383:522-525.
30. World Health Organization, Malaria Unit. 1993. Global malaria control. Bull. W. H. O. 71:281-284.
31. Yang, Y. Z., W. Aswamahasakda, and S. R. Meshnick. 1993. Alkylation of human albumin by the antimalarial artemisinin. Biochem. Pharmacol. 46: 336-339.
32. Yuthavong, Y., P. Butthep, A. Bunyaratvej, and S. Fucharoen. 1989. Decreased sensitivity to artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin Constant Spring erythrocytes. J. Clin. Invest. 83:502-505.
33. Yuthavong, Y., and P. Wilairat. 1993. Protection against malaria by thalassemia and hemoglobin variants. Parasitol. Today 9:241-245.
34. Yuthavong, Y., and P. Wilairat. 1997. Is the high incidence of malaria in α-thalassemic children evidence against the malaria hypothesis? Parasitol. Today 13:207-208.